Skip to main content
. 2017 Apr 25;8(28):45807–45824. doi: 10.18632/oncotarget.17416

Figure 3.

Figure 3

ROC curves for miR-107 in (A) EGFR exon 19 deletion (19DEL), (B) EGFR p.L858R mutation, and (C) EGFR mutation-positive (MUT[+]) patients with NSCLC versus EGFR wild-type (WT) patients.